Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1301-1310 of 2870 for cancer

Edit search filters
  1. ACP-196 In Combination With Pembrolizumab, For Treatment Of Hematologic Malignancies

    Jacksonville, FL, Rochester, MN

  2. Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme

    Rochester, MN

  3. Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP In Newly Diagnosed High-intermediate And High Risk DLBCL Patients

    Jacksonville, FL, Rochester, MN

  4. A Study To Evaluate The Optune® (Tumor Treating Fields) Concomitant With RT & TMZ To Treat Newly-diagnosed Glioblastoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  5. A Study of Endoscopic Ethanol Ablation of Communicating Pancreatic Cystic Neoplasms

    Rochester, MN

  6. The NeoGlioma Study

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Phase II Study Of Bendamustine And Rituximab Plus Venetoclax In Untreated Mantle Cell Lymphoma Over 60 Years Of Age (PrE0405)

    Rochester, MN

  8. MC230818 Understanding the mechanisms of clonal and non-clonal cytopenia following CAR-T therapy (MC230818)

    Albert Lea, MN, Scottsdale/Phoenix, AZ, Eau Claire, WI, Jacksonville, FL, La Crosse, WI, Mankato, MN, Rochester, MN

  9. A Study of Pancreatic Polypeptide Response in Patients with Diabetes Mellitus with and without Pancreatic Cancer

    Rochester, MN

  10. AKT Inhibitor MK2206, Combined with Bendamustine Hydrochloride, and Rituximab for Treating Patients who have Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

.

Mayo Clinic Footer